Sinda Prices IPO Of 17. 75 Mln Shares At $12. 00 / shr

Sinda Ltd. priced its IPO of 17.75 million shares at $12.00 each, according to the company. Underwriters have a 30-day option to buy an additional 2.66 million shares at the same price, less discounts and commissions. Shares are expected to start trading on the NYSE June 26, 2026 (SIND) and close June 29.

Original reporting
Published Jun 26, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 5:25 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sinda Prices IPO Of 17. 75 Mln Shares At $12. 00 / shr — source image
Decision brief

The 30-second read

$SINDNeutralMed
01

Why it matters

For traders, the actionable element is the concrete IPO price ($12.00), the share count (17.75M plus 2.66M over-allotment option), and the expected NYSE start date under ticker SIND.

02

Market read

A fresh IPO pricing/first-trading catalyst for SIND with defined terms and dates.

03

What to watch

No information is provided on Sinda’s financials, use of proceeds, lockups, or investor demand indicators—these can dominate first-week price action.

Relevance 8/10Novelty 8/10Timing: Ahead of/at the start of NYSE trading on June 26, 2026.

Background

The piece reports the pricing terms and expected listing timeline for Sinda’s initial public offering.

Company-level read

Ticker impact

$SINDNeutralMedium confidence
Context

Sinda priced its IPO at $12.00/share for 17.75M shares and plans NYSE trading under ticker SIND starting June 26, 2026.

Expected impact

Near-term volatility likely around the first trading session as the market digests the $12.00 IPO price and deal size.

Evidence & confidence

The article discloses the IPO price, share count, underwriter option size, and expected first trading date, but provides no valuation/financial fundamentals beyond the offering terms.

Market effects

Adds a new public listing in the broader space/tech-adjacent narrative, but the article itself provides no sector fundamentals or read-across metrics.

Primarily US-focused via NYSE listing; limited spillover implied by the text.

Low—no cross-border deal terms or global regulatory actions are described.

Counterpoint

IPO pricing alone may not sustain performance; post-listing trading can quickly diverge if demand was weaker than implied by the offer size.

Key entities

  • Sinda Ltd.

    Announced IPO pricing: 17.75M shares at $12.00/share; NYSE trading expected June 26, 2026 under SIND.

  • Morgan Stanley

    Joint lead book-running manager for the IPO.

  • Scotiabank

    Joint lead book-running manager for the IPO.

  • BMO Capital Markets

    Joint lead book-running manager for the IPO.

Related articles

$SINDMedAI 8/10

Silver miner Sinda raises $323 million in US IPO, placement

Sinda Ltd., a Mexico-based silver miner, raised $323 million in a US IPO and private placement after moving up its debut timeline, according to a company statement. It priced 17.75 million shares at $12 each. Franco-Nevada sought up to $10 million and Fresnillo up to $110 million. Proceeds fund drilling and development; production is targeted for 2031.

$SINDMedAI 8/10

Sinda Prices IPO Of 17.75 Mln Shares At $12.00/shr

Sinda Ltd. priced its IPO at $12.00 per share for 17.75 million shares. The company granted underwriters a 30-day option to buy an additional 2.66 million shares at the same price, minus discounts and commissions. Trading on the NYSE under “SIND” is expected to start June 26, 2026, with closing expected June 29.

$HOODMed

Robinhood’s new venture fund comes with a bold risk label

Robinhood is launching Robinhood Ventures Fund II (ticker RVII), a business development company offering 8 million shares at $25 each starting Aug. 13. The fund plans to raise $200 million, led by Goldman Sachs. It invests in Y Combinator-linked seed startups and charges a 2% management fee plus a 20% incentive fee, with estimated annual expenses of 4.18%. The prospectus labels the offering speculative and warns of potential discounts to net asset value.